Overall, the use of 124I-scFvD2B resulted in high-contrast immuno-PET images of PSMA-positive tumours with low accumulation in non-target organs probably due to the non residualizing properties of its radiocatabolites [28]. Here, FOLH1 is linked to neoplasm.